MedTrace Logo

Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control

NCT06151821 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2023-11-30

No results posted yet for this study

Summary

The study aims to investigate the effects of Guided Meditation on diabetes-related distress and glycemic control in hospitalized Type 1 adolescent diabetic patients. The study will employ a randomized controlled trial design, with participants randomly assigned to either the intervention group (receiving Guided Meditation sessions) or the control group (receiving standard care). The primary outcomes measured will be diabetes-related distress levels and glycemic control (HbA1c levels).

Conditions

  • Type 1 Diabetes Mellitus

Interventions

BEHAVIORAL

Guided meditation

Meditation with guidance

Sponsors & Collaborators

  • Shifa International Hospital

    lead OTHER

Principal Investigators

  • Saima Abbass, MD, MSc · Shifa hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2023-10-02
Completion
2023-10-03

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06151821 on ClinicalTrials.gov